Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
GLPG
GLPG
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GLPG News
Vistra Corp Acquires Cogentrix Energy for Approximately $4.7 Billion
Jan 06 2026
Benzinga
Microchip Technology Raises Q3 FY2026 Sales Guidance to $1.185 Billion
Jan 06 2026
Benzinga
Galapagos GLPG3667 Achieves Significant Clinical Benefit in Dermatomyositis Study
Dec 18 2025
Globenewswire
Galapagos GLPG3667 Achieves Significant Clinical Benefit in Dermatomyositis Study
Dec 18 2025
Newsfilter
Galapagos Achieves Key Objective in Phase 3 Study for Rare Autoimmune Disease Treatment
Dec 18 2025
SeekingAlpha
GLPG Surpasses Average Analyst Expectations
Dec 12 2025
NASDAQ.COM
Galapagos Presents New GLPG5101 Data with 100% Response Rate in MCL Patients
Dec 08 2025
Globenewswire
Galapagos Reports 96% CR Rate for GLPG5101 in MCL Patients at ASH 2025
Dec 08 2025
Newsfilter
Bank of America Increases Galapagos Voting Rights to 5.26%
Nov 26 2025
Newsfilter
GLPG Surpasses Average Analyst Price Target
Oct 29 2025
NASDAQ.COM
Leerink Partners Raises Rating on Galapagos NV - Depositary Receipt (GLPG)
Oct 22 2025
NASDAQ.COM
Galapagos Experiences Decline Following Decision to Close Cell Therapy Division
Oct 21 2025
SeekingAlpha
Galapagos Plans to Cease Cell Therapy Operations in Line with Company's Ongoing Transformation
Oct 21 2025
Newsfilter
Galapagos Attracts Non-Binding Bids for Cell Therapy Division
Oct 02 2025
NASDAQ.COM
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Aug 06 2025
Newsfilter
Tesla Posts Downbeat Earnings, Joins Community Health Systems, Chipotle Mexican Grill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Jul 24 2025
Benzinga
Show More News
